The U.S. Supreme Court has delivered a significant legal win for Bayer, the manufacturer of Roundup weedkiller, by limiting the scope of numerous lawsuits filed by individuals claiming cancer was caused by exposure to glyphosate. The court ruled that federal approval of the product’s warning label shields Bayer from many liability claims, even though the World Health Organization has classified glyphosate as probably carcinogenic. This decision effectively blocks a large number of pending cases, reinforcing the authority of federal regulators in product safety matters.
The ruling has drawn strong criticism from advocacy groups and affected individuals who argue it undermines consumer protection and makes it harder to hold corporations accountable for health risks associated with widely used chemicals. Legal experts note the decision may set a precedent that strengthens federal preemption in product liability cases, potentially affecting future litigation involving other consumer products. The outcome underscores ongoing tensions between regulatory oversight and individual rights to seek compensation for harm.